PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Foreign Biopharma Eyes New Jersey as Top Location

Value-Based Purchasing for Prescription Drugs Takes a Leap Forward in State Medicaid

Connecting the 5 Spheres of People-Based Marketing

Top Story
Congress, Feds, FDA Take Action to Combat Opioid Crisis
Jill Wechsler details recent the bipartisan action to support treatment of opioid abusers and deter inappropriate drug prescribing and illegal distribution
/Read more/
Advertisement
The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.
Explore now
Global
Pathways to Potential in Europe's Pharmerging Markets
Filip Conic outlines the market-access approaches and commercial strategies to unlock the growth potential in the Southeastern and Eastern European region
/Read more/
Advertisement
Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.
Read more
Technology
Pragmatic AI in Pharma
Ron Wince explains how Pragmatic AI allows organizations to start with the basics, create immediate business value and ROI and then increase adoption as their comfort, capabilities and confidence increases
/Read more/
Advertisement
A Framework for Successful Biopharma Launches Understanding the launch archetype and identifying critical success factors
Wednesday, July 11, 2018 at 2pm EDT
Register now
Calendar
/ August 7–8: Bio/Pharma Compliance Congress on Non-Promotional Activities /
Philadelphia, PA
/ August 14–15: Publication Planning 2018 /
Philadelphia, PA
/ August 15–16: Reimbursement and Access 2018 /
Philadelphia, PA
/ August 20–22: Transparency and Aggregate Spend 2018 /
Washington, DA, PA
/ September 25–26: Finance and Accounting for Bioscience Companies /
Boston, MA
/ September 25–26: 4th Annual Bio/Pharmaceutical Product Launch Summit /
Cambridge, MA
/ September 27: 3rd Edition Drug Pricing Transparency Congress /
Philadelphia, PA
/ October 2–3: Advanced Therapies Commercialization Congress /
Amsterdam, The Netherlands
/ November 13–14: Commercial Data Insights 2018 /
Philadelphia, PA
/ November 13–14: Due Diligence for Life Sciences M&A, Partnerships and Divestitures /
Philadelphia, PA
/ November 14–15: Compliant Patient Support Programs Summit /
Chicago, IL
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences /
London, UK
/ December 4–5: Managed Markets Compliance Congress 2018 /
Philadelphia, PA
Technology
Regulatory Information Management: Current and Future States
Steve Gens talks to Pharm Exec about the evolution of Regulatory Information Management (RIM) and offers some predictions for 2022
/Read More/
Advertisement
Evolving Life Sciences Quality Management: Keeping Up with the New Reality
On Demand
Learn more
Event
How to Run Your Biotech Like the Kraft Family Runs the New England Patriots
At this year's BIO International Convention, Jonathan Kraft shared his family's secrets on what it takes to lead a successful organization, while also creating lasting brand power
/Read more/
Advertisement
Combination Therapies in Oncology: The Benefits of Integrated Insights
On Demand
Learn more
Audio
The Pharm Exec Podcast: From Sports Field to Boardroom
The Pharm Exec editors talk former NFL star and current sports broadcaster, Solomon Wilcots, about the intersection of sports and biopharma, and how lessons from the football field can be applied to the boardroom
/Click here to listen/
Industry update
// Ritter Pharmaceuticals (Los Angeles, CA) appointed Andrew J. Ritter as CEO, succeeding Michael D. Step, who will remain on the company's board of directors and serve as a consultant to the company. // Marina Biotech (City of Industry, CA) appointed Robert C. Moscato, Jr. as Chief Executive Officer. The company also announced that Mr. Moscato and Uli Hacksell, Ph.D. were appointed to its Board of Directors, with Dr. Hacksell also appointed to serve as Chairman of the Board. // Supernus Pharmaceuticals (Rockville, MD) announced that Dr. Carrolee Barlow, M.D., Ph.D., has joined the company's Board of Directors. // Raffaella Giardino, Ph.D. joined Microbiologics (Saint Cloud, MN) as Executive Director, International Sales. // Fluidigm Corporation (South San Francisco, CA) announced the appointment of David King as Vice President, Research and Development, Genomics. // Dova Pharmaceuticals, announced that Nancy J. Wysenski joined the company's Board of Directors. Ms. Wysenki will also serve on Dova's Compensation Committee and the Nominating and Corporate Governance Committee. //
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com